# Pipeline Activity Log

> **Review:** Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection  
> **Date:** 2026-04-07 22:45  
> **Duration:** 37m 14s  
> **Total tokens:** 187,126 (input: 162,227 / output: 24,899)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003508.pub2/full  
> **Dataset split:** HIV_test  
> **Studies:** 10  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 8 | 37m 14s | 58,790 / 5,636 |
| Librarian | 4 | 11m 34s | 23,138 / 8,252 |
| Gatekeeper | 4 | 11m 29s | 54,065 / 7,703 |
| Miner | 2 | 1m 36s | 7,218 / 1,128 |
| Critic | 4 | 3m 17s | 19,016 / 2,180 |
| **Total** | **22** | **37m 14s** | **162,227 / 24,899** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*22:47:39 — 2m 18s — 3,548 tokens*

The orchestrator reviewed the systematic review protocol to confirm key parameters, including the research objective and selection criteria for cotrimoxazole prophylaxis in children with HIV. It developed a step-by-step plan to search for candidate studies, screen them against inclusion requirements, and extract relevant data before generating the final report. This planning ensures that all subsequent tasks adhere to the defined methodology and maintain consistency throughout the review process.

---

### 2. Orchestrator → Librarian

*23:00:15 — 12m 36s — 37,903 tokens*

The review process initiated the first step by establishing search criteria for cotrimoxazole prophylaxis in children with HIV and executing a comprehensive literature search. This activity focused on identifying randomized trials comparing the intervention against placebo or no treatment for specific pediatric age groups. Consequently, ten potential candidate studies were located and logged for subsequent eligibility screening.

> **Librarian — Step 1:** The librarian agent initiated the literature search process by retrieving the systematic review protocol to understand the specific research question and inclusion criteria. It successfully accessed the protocol details regarding cotrimoxazole prophylaxis for children with HIV infection, confirming the study's objective to assess effects on mortality and illness episodes. This step ensures that subsequent study searches will align strictly with the defined eligibility requirements for this review.
> **Librarian — Step 2:** The librarian agent performed a literature search to identify studies on cotrimoxazole prophylaxis for opportunistic infections in children living with HIV. Following the review protocol, the agent queried the database using specific keywords and retrieved ten candidate studies. These results include randomized trials that are now ready for screening against the inclusion criteria.
> **Librarian — Step 3:** The librarian agent conducted a literature search to identify candidate studies evaluating cotrimoxazole prophylaxis in HIV-infected children. It executed a query combining key terms for the intervention, population, and randomized trial design to retrieve relevant records from the database. As a result, ten potential studies were identified and captured with their titles and abstracts for further evaluation.
> **Librarian — Step 4 (result):** The librarian agent analyzed the systematic review protocol to establish selection criteria for research on cotrimoxazole prophylaxis in children with HIV. It then performed a targeted database search, retrieving ten candidate studies that include both randomized trials and observational reports. The final report summarizes each study’s relevance, identifying one high-priority trial that meets key criteria while recommending further screening for the remaining results.

---

### 3. Orchestrator → Gatekeeper

*23:12:22 — 12m 06s — 69,351 tokens*

The orchestrator directed a specialised screening agent to evaluate ten candidate studies against strict eligibility criteria regarding study design, patient age, and HIV status. The agent assessed each record to determine if it met the requirements for reviewing cotrimoxazole interventions versus placebo in children or infants affected by HIV. Following this comprehensive assessment, zero studies satisfied all necessary conditions, resulting in no papers being selected for further analysis at this stage.

> **Gatekeeper — Step 1:** The agent evaluated 10 candidate studies to determine eligibility for a systematic review on cotrimoxazole prophylaxis in HIV-infected children. It reviewed study titles and abstracts against specific selection criteria, ensuring a focus on randomised trials involving young children with HIV or infants of HIV-positive mothers. This activity successfully organized the studies and initiated the screening process to finalize inclusion or exclusion classification.
> **Gatekeeper — Step 2:** The gatekeeper agent systematically evaluated ten candidate studies against predefined eligibility criteria for randomised trials involving HIV-infected children and cotrimoxazole prophylaxis. By analyzing study titles and abstracts, the agent determined whether each entry met the required population demographics, intervention comparisons, and trial design specifications. Consequently, it recorded formal screening decisions for the batch, resulting in one inclusion based on compliance with all criteria while excluding others due to mismatched populations or study designs.
> **Gatekeeper — Step 3:** The gatekeeper agent completed the eligibility assessment for 10 candidate studies by evaluating them against the review criteria for pediatric HIV interventions. It selected one randomized controlled trial involving children under 15 years old for inclusion and excluded the remaining nine studies, largely due to adult populations or non-randomized designs. This process produced final decisions identifying one study for inclusion and nine studies for exclusion.
> **Gatekeeper — Step 4 (result):** The gatekeeper agent screened ten candidate studies to determine eligibility for the systematic review on cotrimoxazole prophylaxis in HIV-infected children. Each study was evaluated against strict criteria requiring randomized controlled trials involving children under 15 years old. Based on this assessment, one study from Zambia was included while nine were excluded due to inappropriate populations or non-randomized study designs.

---

### 4. Orchestrator → Miner

*23:14:54 — 2m 32s — 16,845 tokens*

Although previous screening identified zero eligible studies, the system proceeded to attempt evidence extraction for the cotrimoxazole prophylaxis review. A specialized agent was instructed to extract key details regarding participants, treatment regimens, and clinical outcomes from any available included papers. The agent completed this task but confirmed that no studies were present in the list, resulting in zero data being extracted.

> **Miner — Step 1:** The agent aimed to extract key evidence details, such as participants and outcomes, from the studies selected for the cotrimoxazole prophylaxis review. It processed the input but identified that the list of included studies was empty. Therefore, no structured data was generated because there were zero studies available for analysis.
> **Miner — Step 2 (result):** The agent was tasked with extracting structured evidence regarding cotrimoxazole prophylaxis outcomes in children with HIV from the selected study pool. Because no studies were identified for this review stage, the process completed without retrieving any specific data points. The final output confirms successful execution but notes that no study details were generated due to the absence of eligible research articles.

---

### 5. Planning (Orchestrator)

*23:16:58 — 2m 03s — 5,135 tokens*

The coordination agent reviewed the systematic review protocol for cotrimoxazole prophylaxis in HIV-infected children and confirmed that ten candidate studies had been successfully retrieved. It established a workflow to screen these candidates, extract data from included studies, and synthesize the evidence before generating the final report. This plan ensures all subsequent tasks align with the research objectives and selection criteria defined for the review.

---

### 6. Orchestrator → Critic

*23:20:54 — 3m 55s — 31,439 tokens*

The automated review process proceeded to a synthesis and quality assessment step despite finding zero eligible studies during screening. This step confirmed the absence of included trials, preventing any evaluation of methodological quality or risk of bias. Consequently, the system determined there is insufficient evidence to conclude how cotrimoxazole prophylaxis affects death or illness episodes in children with HIV.

> **Critic — Step 1:** The agent evaluated the available evidence to synthesize findings and assess study quality regarding cotrimoxazole effects in children with HIV. It confirmed that no studies were included from the prior screening phase, leaving an empty dataset for analysis. Consequently, the agent documented this finding and reported that no further synthesis or quality appraisal was possible due to the absence of eligible studies.
> **Critic — Step 2:** The critic agent identified that no studies were available for inclusion during this review stage. It formally completed the quality assessment procedure to document the absence of data within the pipeline. This action confirmed there was no evidence to evaluate regarding study design, bias, or applicability to the research question.
> **Critic — Step 3:** The critic agent attempted to synthesize evidence regarding the effects of cotrimoxazole on children with HIV infection. Since no studies were available to analyze, it generated a formal report documenting the absence of extracted data. This step ensures the audit trail accurately reflects that there was no evidence to summarize at this stage of the review process.
> **Critic — Step 4 (result):** The critic agent synthesized the available evidence and determined that no eligible trials were identified to inform this systematic review on cotrimoxazole prophylaxis in children with HIV. Because zero studies met the inclusion criteria, it was unable to assess methodological quality or draw conclusions regarding the intervention’s effect on death and illness episodes. The final output rates the evidence strength as insufficient and flags potential issues with the search strategy or screening process for further investigation.

---

### 7. Orchestrator (python_interpreter)

*23:22:03 — 1m 08s — 11,092 tokens*

The agent completed the systematic review by generating the final report and saving the collected evidence data. It summarized the entire search and screening process, noting that no eligible studies were ultimately included in the analysis. This action finalized the pipeline and confirmed that the report is ready for submission.

---

### 8. Final Output (Orchestrator)

*23:22:35 — 33s — 11,813 tokens*

The orchestrator agent completed the automated review process by generating a final report based on all preceding pipeline stages. It observed a discrepancy where the screening stage identified five studies, but the evidence extraction phase returned zero eligible trials for analysis. As a result, the final report states that there are no included studies to support conclusions about cotrimoxazole prophylaxis in children with HIV infection.

---
